A case report and literature review of metastatic prostate cancer with primary hyperfibrinolysis as the first presentation
10.3760/cma.j.cn101721-20230817-00028
- VernacularTitle:以原发性纤溶亢进为首发表现的转移性前列腺癌1例报告并文献复习
- Author:
Yuhua SONG
1
;
Peng PENG
;
Hua LU
;
Qiqiang LONG
Author Information
1. 南京中医药大学附属南京医院 南京市第二医院血液科，南京 210003
- Keywords:
Metastatic prostate cancer;
Hemorrhagic syndrome;
Primary hyperfibrinolysis;
Antifibrinolytics;
Antiandrogen
- From:
Clinical Medicine of China
2023;39(6):471-474
- CountryChina
- Language:Chinese
-
Abstract:
We reported a rare case with metastatic prostate cancer complicated with hemorrhagic syndrome caused byprimary hyperfibrinolysis.The correct diagnosis of bleeding disorders is a prerequisite for choosing the correct treatment.Tranexamic acid can be used as the preferred treatment for patients with bleeding caused by primary hyperfibrinolysis. In this case, the combination of antifibrinolytics and antiandrogen therapy effectively controlled the severe bleeding symptoms caused by primary hyperfibrinolysis in metastatic prostate cancer. Appropriate treatment after early diagnosis is essential to prevent bleeding and improve prognosis.
